Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AIMS: Flucloxacillin dosing may be guided by measurement of its total plasma concentrations. Flucloxacillin is highly protein bound with fraction unbound in plasma (fu ) of around 0.04 in healthy individuals. The utility of measuring unbound flucloxacillin concentrations for patients outside the intensive care unit (ICU) is not established. We aimed to compare flucloxacillin fu in non-ICU hospitalised patients against healthy volunteers, and to examine the performance of a published model for predicting unbound concentrations, using total flucloxacillin and plasma albumin concentrations. METHODS: Data from 12 healthy volunteers (248 samples) and 47 hospitalized patients (61 samples) were examined. Plasma flucloxacillin concentrations were measured using a validated liquid chromatography-tandem mass spectrometry method. Flucloxacillin fu for the two groups was compared using a generalized estimating equation model to account for clustered observations. The performance of the single protein binding site prediction model in hospitalized patients was compared with measured unbound concentrations using Bland-Altman plots. RESULTS: The median (range) flucloxacillin fu for healthy (median albumin 45 g l-1 ) and hospitalized individuals (median albumin 30 g l-1 ) were 0.04 (0.02-0.07) and 0.10 (0.05-0.37), respectively (P 

Original publication

DOI

10.1111/bcp.13673

Type

Journal article

Journal

Br J Clin Pharmacol

Publication Date

10/2018

Volume

84

Pages

2311 - 2316

Keywords

biological models, drug monitoring, flucloxacillin, protein binding, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Bacteremia, Chromatography, High Pressure Liquid, Dose-Response Relationship, Drug, Female, Floxacillin, Healthy Volunteers, Hospitalization, Humans, Male, Middle Aged, Models, Biological, Plasma, Serum Albumin, Human, Staphylococcal Infections, Staphylococcus aureus, Tandem Mass Spectrometry, Young Adult